Ensign has been a dividend-paying company since 2002.

Earlier this year MSD exercised its option on a separate Evaxion vaccine candidate, EVX-B3. Evaxion is eligible for milestone payments up to $592 million associated with the development of EVX-B3, as ...

ProPhase Labs, Inc. (NASDAQ: PRPH) ("ProPhase") and Advanced Biological Laboratories S.A. ("ABL"), a European biotechnology and MedTech group, today announced that they have entered into a non-binding ...

The Opening Bell ceremony will be broadcast live at 9:30 a.m. ET and live streamed to Nasdaq's official channels. To view the live broadcast, visit: ...

Participants receiving pemvidutide 1.2 mg and 1.8 mg achieved weight loss of 4.5% and 7.5%, respectively, vs. 0.2% of placebo-treated participants (p<0.0001, both doses), with no plateauing at 48 ...

Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today ...

GUERBET (FR0000032526 GBT), a global player in medical imaging, announces the appointment of François Convenant as Senior Vice President of Interventional Radiology. In this role, he joins the Guerbet ...

As calculated in accordance with SEC rules, as of December 19, 2025, Mr. Paracchi owns 2,326,129 ADSs and ordinary shares in the aggregate, representing approximately 10% of Genenta’s outstanding ...

The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems provider, is pleased to announce that ...

Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone ...

The 2024–25 Sustainability Report reflects the company’s long-term view—one that places science, responsibility, and collaboration at the centre of its growth ambition. As Sai Life Sciences continues ...

Louvain-La-Neuve, Belgium, 19 December 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology with a preeminent position in nuclear medicine, acquires ...